Invesco Ltd. Y M Abs Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 14,556 shares of YMAB stock, worth $118,631. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,556

Previous 14,227 2.31%

Holding current value

$118,631

Previous $171,000 11.7%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$9.95 - $15.39 $3,273 - $5,063	329 Added 2.31%	14,556 $191,000
Q2 2024 Aug 13, 2024	BUY	$11.6 - $17.25 $10,892 - $16,197	939 Added 7.07%	14,227 $171,000
Q1 2024 May 14, 2024	BUY	$6.57 - $18.69 $177 - $504	27 Added 0.2%	13,288 $216,000
Q4 2023 Feb 12, 2024	BUY	$4.88 - $7.42 $7,207 - $10,959	1,477 Added 12.53%	13,261 $90,000
Q2 2023 Aug 11, 2023	SELL	$5.68 - $10.34 $9,917 - $18,053	-1,746 Reduced 12.9%	11,784 $80,000
Q1 2023 May 12, 2023	SELL	$2.83 - $5.11 $2,317 - $4,185	-819 Reduced 5.71%	13,530 $67,000
Q4 2022 Feb 13, 2023	SELL	$3.0 - $15.17 $7,362 - $37,227	-2,454 Reduced 14.6%	14,349 $70,000
Q3 2022 Nov 14, 2022	SELL	$13.96 - $19.67 $1.38 Million - $1.94 Million	-98,499 Reduced 85.43%	16,803 $242,000
Q2 2022 Aug 15, 2022	BUY	$8.22 - $15.13 $823,298 - $1.52 Million	100,158 Added 661.37%	115,302 $1.75 Million
Q1 2022 May 16, 2022	BUY	$6.55 - $17.42 $727 - $1,933	111 Added 0.74%	15,144 $180,000
Q4 2021 Feb 14, 2022	SELL	$15.51 - $29.31 $21,651 - $40,916	-1,396 Reduced 8.5%	15,033 $244,000
Q3 2021 Nov 15, 2021	BUY	$27.47 - $37.31 $70,405 - $95,625	2,563 Added 18.48%	16,429 $469,000
Q2 2021 Aug 17, 2021	BUY	$25.45 - $37.64 $136,488 - $201,863	5,363 Added 63.07%	13,866 $468,000
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $63,248 - $112,701	2,169 Added 34.24%	8,503 $257,000
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $239,805 - $343,682	6,334 New	6,334 $314,000
Q3 2020 Nov 16, 2020	SELL	$35.13 - $43.62 $2.99 Million - $3.71 Million	-85,061 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$23.66 - $49.53 $2.01 Million - $4.21 Million	85,061 New	85,061 $3.67 Million

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account